Resultats globals: 1 registres trobats en 0.01 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
12 p, 764.9 KB Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine : A Post Hoc Analysis / Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Samaan, Karen H. (Eli Lilly and Company) ; Schwedt, Todd J. (Mayo Clinic) ; Nicholson, Robert A. (Eli Lilly and Company) ; Rettiganti, Mallikarjuna (Eli Lilly and Company) ; Pearlman, Eric M. (Eli Lilly and Company) ; Universitat Autònoma de Barcelona
The consistency of the treatment effect of galcanezumab throughout the dosing interval is examined in patients with episodic and chronic migraine. This study was a post hoc analysis of clinical trial data from episodic (EVOLVE-1; EVOLVE-2; both 6-month duration) and chronic (REGAIN; 3-month duration) migraine double-blind trials evaluating the efficacy of a once-monthly injection of galcanezumab 120 mg relative to placebo. [...]
2021 - 10.1007/s12325-021-01708-8
Advances in Therapy, Vol. 38 (may 2021) , p. 3154-3165  

Vegeu també: autors amb noms similars
21 Nicholson, Roger
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.